Table 2.
Biochemical characteristics and Malnutrition screening indices of the study population stratified by COVID-19 severity.
| Variable | Total | COVID-19 Severity |
p-value |
||
|---|---|---|---|---|---|
| ICU | Non-ICU | ||||
| White blood cell count, median (IQR), × 109 /L | 7.60(5.4–10.75) | 8.45 (6.25–12.2) | 6.80 (5.2–10.25) | 0.001 | |
| Absolute Neutrophils Count, median (IQR), × 109 /L | 6.09 (4–9.32) | 7.41 (5.23–10.79) | 5.36 (3.81–8.4) | < 0.001 | |
| Absolute Lymphocyte Count, median (IQR), × 109 /L | 0.83 (0.56–1.23) | 0.64 (0.44–0.97) | 0.96 (0.64–1.31) | < 0.001 | |
| Platelet count, mean ± SD, × 109 /L | 241.32 ± 92.27 | 236.44 ± 88.84 | 243.45 ± 93.86 | 0.553 | |
| Serum Albumin, median (IQR), g/L | 36.00 (32–39) | 34.00 (31–36) | 37.00 (33–40) | < 0.001 | |
| C-reactive protein, median (IQR), mg/L | 9.45 (4.18–15.99) | 11.34 (5.61–21.1) | 8.61 (3.74–15.07) | 0.021 | |
| D-Dimer, median (IQR), ng/mL | 336.00 (154–925) | 526.00 (195–1600) | 280.50 (142–777.5) | 0.005 | |
| Malnutrition screening indices, median (IQR) | |||||
| PNI | 40.47 (36.12–44.47) | 37.26 (33.71–41.52) | 41.29 (38.11–45.59) | < 0.001 | |
| PLR | 266.67 (177.25–423.67) | 339.68 (224.25–519.66) | 243.06 (161.37–384.01) | < 0.001 | |
| NLR | 7.64 (4.05–13) | 11.63 (7.75–18.35) | 5.93 (3.24–10.69) | < 0.001 | |
| ANDC | 62.01 (46.74–81.13) | 80.33 (68.46–96.7) | 55.14 (43.04–70.54) | < 0.001 | |
ICU: intensive care unit; PNI: the prognostic nutrition index; NLR: neutrophil-to-lymphocyte ratio; NLR: neutrophil-to-lymphocyte ratio; ANDC: an early warning score to predict mortality risk.